LONDON - Advanced trials of a new mosquito medicine that began in Africa last week could lead to the world's first malaria vaccine becoming available as soon as 2011, a newspaper reported on Monday.
GlaxoSmithKline (GSK) began Phase-III trials of its Mosquirix medicine on Wednesday as scientists began injecting 1,200 infants and children in the town of Bagamoyo in Tanzania.
Eventually, up to 16,000 patients will be immunised in seven African countries, including Mozambique, Kenya and Malawi. .
Click here to read the entire story.
Latest from Pest Control Technology
- Envu Announces Launch of New Rewards Program
- Regulations, Science and Strategy Take Center Stage at Purdue Conference
- Selling Pest Control in the 21st Century
- Purdue Pest Management Conference Marks 90 Years
- Rentokil Initial Appoints Mike Duffy as CEO
- Harry Bryan Named VP of Business Development for Nisus Corporation
- Douglas Products Announces Planned CEO Transition
- Industry Veteran Richard Cruz Joins VM Products
